DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates

DarioHealth reported a quarterly EPS loss of $0.80 vs. the Zacks consensus loss of $1.57, beating estimates by $0.77. This compares with EPS of $0.20 a year ago, a year-over-year swing of $1.00 to a loss, indicating an expectation beat despite continued unprofitability.

Analysis

DarioHealth reported a quarterly EPS loss of $0.80 vs. the Zacks consensus loss of $1.57, beating estimates by $0.77. This compares with EPS of $0.20 a year ago, a year-over-year swing of $1.00 to a loss, indicating an expectation beat despite continued unprofitability.